From: Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
Case number | Disease status | Age at death | Sex | Death to TPT | DD | Cause of death |
---|---|---|---|---|---|---|
MS055 | SPMS | 47 | F | 15 | 32 | Pneumonia |
MS058 | SPMS | 51 | F | 15 | 21 | MS |
MS061 | PRMS | 56 | F | 6 | >15 | Adenocarcinoma |
MS064 | SPMS | 66 | M | 56 | 28 | Pneumonia |
MS128 | SPMS | 78 | F | 22 | 50 | Pneumonia |
MS179 | SPMS | 70 | F | 20 | 25 | Pneumonia |
MS306 | SPMS | 78 | M | 17 | 42 | Clostridium difficile diarrhoea |
MS307 | SPMS | 55 | M | 19 | 20 | MS |
MS312 | SPMS | 68 | F | 24 | 23 | Urinary sepsis |
MS372 | SPMS | 82 | F | 7 | 46 | Pneumonia |
MS383 | PPMS | 42 | M | 17 | 8 | Pneumonia |
MS24 | PPMS | 71 | F | 96 | 22 | Pneumonia |
MS160 | SPMS | 44 | F | 18 | 16 | Pneumonia |
MS225 | SPMS | 79 | F | 23 | 32 | MS, Diabetes mellitus, deep vein thrombosis |
MS230 | SPMS | 42 | F | 31 | 19 | MS |
MS234 | SPMS | 39 | F | 15 | 15 | Pulmonary embolism/Pneumonia |
MS377 | SPMS | 50 | F | 22 | 23 | Pneumonia |
C21 | C | 91 | F | 127 | N/A | Pneumonia |
C29 | C | 71 | M | 33 | N/A | Abdominal haemorrhage |
C23 | NC | 93 | F | 51 | N/A | Alzheimer’s disease |
C36 | C | 68 | M | 30 | N/A | Cryptogenic fibrosing alveolitis |
C37 | C | 84 | M | 5 | N/A | Pneumonia, bladder cancer |
C38 | C | 85 | M | 27 | N/A | Ischaemic heart disease |
C39 | C | 82 | M | 21 | N/A | Myelodysplastic syndrome |
C40 | NC | 86 | F | 29 | N/A | Acute cortical ischemic infarction |
C41 | C | 54 | M | 20 | N/A | Lung cancer |
NP7407-2 | NC | 93 | F | 24 | N/A | Acute cortical ischemic infarction |
1228/91-b | NC | 88 | F | 24 | N/A | Acute cortical ischemic infarction |
A140_07 | NC | 81 | F | 17 | N/A | Alzheimer’s disease |
A173_08 | NC | 85 | F | 30 | N/A | Alzheimer’s disease |
A192_2 | NC | 96 | F | 19 | N/A | Alzheimer’s disease |
B5046-15 | NC | 42 | M | 72 | N/A | Herpes simplex encephalitis |
B5125-9 | NC | 54 | M | 96 | N/A | Herpes simplex encephalitis |